To assess sex differences in associations, we performed step 1 MR (BMI to C-terminal COL6A3) and step 2 MR (C-terminal COL6A3 to CAD risk) in a sex-stratified manner. This evidence concerns the gene COL6A3 and coronary artery disorder.